- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04859699
Reopening Schools Safely and Educating Youth Research Study (ROSSEY)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVE:
Aim 1. Identify the rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain onsite learning using qualitative assessments with school stakeholders, parents, and students.
Aim 2. Evaluate the effectiveness of risk communication on student attendance and participation in SARS-CoV-2 testing using a cluster randomized controlled trial (RCT) with two intervention arms: intervention (SARS-CoV-2 Risk Communication) and comparison (control group) arm.
Aim 3. Assess implementation outcomes of the Yakima School District testing program and risk communication intervention with school stakeholders, parents, and children guided by the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework.
OVERVIEW:
The study has three aims and involves a clustered randomized controlled trial (RCT) where K-5 elementary schools will be the unit of randomization. Aim 1 will involve conducting qualitative assessments with school stakeholders, parents and students to to assess social, ethical, cultural, and behavioral concerns related to COVID-19 in the community. This data will be used to guide the development of the risk communication strategies (e.g., comic books and videos). Aim 2 includes a clustered RCT conducted in Yakima School District elementary schools to evaluate the effect of risk communication on testing uptake. We will assess primary outcome on students; parent/guardian will provide informed consent through either an online, paper, or telephone process to enroll in the study. Following consent, parent/guardians of participants will receive instructions on study procedures and complete the enrollment questionnaire either via online, on paper, or over the telephone with a study staff member. If the students attend a school that is randomized into the intervention group, they will receive the risk communication as three comic books and their parents will receive two videos at regular intervals throughout the study in English and Spanish. The communication intervention will highlight benefits of and address barriers to preventative behaviors, SARS-CoV-2 testing, and COVID-19 vaccines. Participants in the comparison group will receive the risk communication comic books and videos at the end of the study as part of the delayed intervention. Secondary outcome measures will be assessed for one index child in all families who have children enrolled in the study.
To prepare for this large trial, the study will institute a pilot study conducting weekly novel coronavirus surveillance testing in one school during April - June 2021 to understand the implementation steps and the workflow of working with schools. The larger RCT trial will be implemented in 14 K-5 schools in Fall 2021 - Spring 2023 school year.
All students in the Yakima School District has access to the Yakima School District's COVID-19 static testing site. Screening and symptomatic testing will be available (but not mandated) to Yakima School District students through the static site. School attendance and SARS-CoV-2 test results on students enrolled in our research study will come from schools.
STUDY POPULATION:
The schools participating in the study come from an agricultural region of Washington state.
STUDY TIME PERIOD:
August 2021-March 2023.
STATISTICAL ANALYSES: The primary analysis will be based on the average number of onsite learning hours per week over the study period for each student. The data will be analyzed using a linear mixed effects model with district and randomization arm as fixed effects, and school and classroom within school as random effects. Analyses will test for any difference between the randomization arms using α = 0.05 and report the comparisons between arms.
STUDY OUTCOMES:
The primary outcome for children will be absenteeism (hours per week missing onsite learning).
The secondary outcome will be assessed in parent/child dyads. Parents will share their child's physical activity and emotional regulation; and will be assessed for perceived stress, COVID-related stress, and depressive symptomatology for parents.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sonia Bishop
- Phone Number: 206-685-2947
- Email: skbishop@uw.edu
Study Contact Backup
- Name: Miriana Duran
- Phone Number: 206-221-6206
- Email: mdp19@uw.edu
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98109
- Recruiting
- University of Washington
-
Contact:
- Linda K Ko, PhD
- Phone Number: 206-685-4978
- Email: lindako@uw.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participant attends or works in a participating school for at least 2 days/week.
- Participant must be willing to comply with all study procedures, including weekly online check-ins and phone interviews.
- Participant should have consistent and reliable Internet access, either by smart phone or computer.
- Participant must be comfortable speaking English or Spanish.
- Participant must be able to provide online informed consent and/or legal guardian assent.
Exclusion Criteria:
- Individuals unable to provide informed consent / assent, except in cases where the participant has an available legal authorized representative and/or parent
- Individuals who are incarcerated
- Individuals with conditions that may preclude or limit the participant's ability to comply with study procedures, according to the investigators
- Children who are wards of the state and who have clinically-diagnosed dementia, terminal (<5 years) illness, major psychiatric illness, severe hearing impairment, and inability to move, which will be assessed during the distribution of the study recruitment packets to families.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
This arm will include schools and the enrolled families assigned as the control group, who will not receive the COVID-19 health education comic books and video intervention.
|
|
Active Comparator: COVID-19 Comic Books and Videos
This arm will include schools that are randomized to receive the health education with comic books and videos focused on the benefits of preventive measures for COVID-19.
|
Comic books and videos will be shared with intervention students and their parents to provide education on COVID-19 topics such as masking, social distancing and COVID-19 testing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
School absenteeism
Time Frame: Up to nine months
|
How many days of school do students miss due to symptoms of respiratory illness
|
Up to nine months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Emotional regulation of children
Time Frame: Up to once per month over a nine month period
|
Children will be assessed for physical activity levels and emotional regulation using qualitative one-on-one interviews and focus groups with their parents enrolled in the study.
|
Up to once per month over a nine month period
|
Perceived stress of parents and staff
Time Frame: Up to once per month over a nine month period
|
Parents of enrolled children and enrolled staff members will be assessed for perceived stress using a combination of qualitative one-on-one interviews and focus groups over the course of the study.
|
Up to once per month over a nine month period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Linda Ko, PhD, MPH, University of Washington
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00014531-A
- 1OT2HD107544-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Absenteeism
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingAbsenteeismUnited States
-
University of WuerzburgSOMA Analytics UKCompleted
-
University of North Carolina, Chapel HillGeneral MillsCompletedChildren's Health and Growth | Childcare AbsenteeismUnited States
-
KU LeuvenNational Institute for Health and Disability Insurance (NIHDI), Belgium; Haute...RecruitingAbsenteeism | Return to Work | Sick LeaveBelgium
-
Duke UniversityU.S. Department of EducationCompletedExcessive Absenteeism by Primary School StudentsUnited States
-
Hebrew University of JerusalemHadassah Medical Organization; Ministry of Health, Israel; Israel National Institute... and other collaboratorsCompleted
-
University of Southern DenmarkSonderborg MunicipalityCompleted
-
International Centre for Diarrhoeal Disease Research...Columbia UniversityCompletedSchool AbsenteeismBangladesh
-
University of AarhusInnovation Fund Denmark; TRYG Foundation; The Danish Mental Health Foundation; Aarhus...CompletedDepressive Symptoms | Anxiety Symptoms | Behavioral Problem | School AbsenteeismDenmark
-
Centers for Disease Control and PreventionProcter and Gamble; Centers for Disease Control and Prevention, China; Zhejiang... and other collaboratorsCompletedInfectious Disease | Absenteeism | Respiratory IllnessChina, Pakistan, Philippines
Clinical Trials on COVID-19 Health Education Comic Books and Videos
-
Argentina Servin, MD, MPHNational Institute on Minority Health and Health Disparities (NIMHD); San Ysidro...CompletedCovid19 | Vaccine RefusalUnited States
-
Scripps Translational Science InstituteCue HealthRecruitingImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsHIV Infections | Lymphoma | Leukemia | Cancer | Multiple Myeloma | Immunosuppression | Immunodeficiency | Transplant | Graft Versus Host Disease | Age-Related ImmunodeficiencyUnited States
-
University of RochesterEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruiting
-
University of ChileNot yet recruitingCovid19 | Death | Infectious Disease | SARS-CoV InfectionChile
-
Xavier University of Louisiana.CompletedCovid19 | Vaccine Hesitancy | Vaccine RefusalUnited States
-
Kilis 7 Aralik UniversityCompleted
-
University of California, San DiegoNational Institute on Drug Abuse (NIDA)Completed
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); Duke University and other collaboratorsTerminatedVaccine Hesitancy | Covid-19 VaccineUnited States
-
Duke UniversityNational Institutes of Health (NIH)Recruiting
-
NYU Langone HealthAgency for Healthcare Research and Quality (AHRQ)Not yet recruitingType 2 DiabetesUnited States